Clinical Trials Browser

OTHER × Diclofenac × Clear all

NCT06731270 2026-02-12

Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02636569 2026-01-21

Topical Chemoprevention of Skin Cancer Biomarkers

Phase 2 Completed

Non-melanoma Skin Cancer

NCT04091022 2025-12-17

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

Phase 2 Completed

Non-melanoma Skin Cancer

NCT05641246 2024-01-03

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Phase 2 Completed

Breast Neoplasms, Hand-Foot Syndrome

NCT05829707 2023-04-28

Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia

Phase 4 Completed

Breast Neoplasms, Pain, Postoperative

NCT04511832 2022-07-20

Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors

Phase NA Completed

Breast Neoplasms

NCT05121233 2021-11-16

Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided Procedures

Phase 4 Unknown

Lung Neoplasms, Pleural Effusion, Pleural Neoplasms, Pneumothorax, Empyema, Pleural, Respiratory Aspiration

NCT03831321 2019-02-05

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Phase 4 Unknown

Urinary Bladder Neoplasms, Hematuria, Pain, Prostatic Hyperplasia, Lower Urinary Tract Symptoms

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03090971 2017-10-26

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

Phase 2 Completed

Neurofibromatosis 1

NCT00601640 2017-03-23

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

Phase 2 Completed

184 enrolled 9 charts

Skin Neoplasms

NCT01935531 2016-03-31

Effects of Topical Diclofenac on Tumor Metabolism

Phase 4 Completed

Keratosis, Actinic

NCT01358045 2015-01-13

Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

Phase 2 Completed

Carcinoma, Basal Cell

NCT00204542 2011-08-19

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

Phase 4 Completed

Photosensitivity Disorders, Keratosis, Actinic